The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan, an anti-HER2 antibody-drug conjugate

J. Lee; K. Kida; H. Liu; Y. J. Gi; G. Manyam; J. Wang; A. Multani; L. Huo; D. Tripathy; N. Ueno

doi:10.1016/S0959-8049(22)00941-8

The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan, an anti-HER2 antibody-drug conjugate

J. Lee
, K. Kida
, H. Liu
, Y. J. Gi
, G. Manyam
, J. Wang
, A. Multani
, L. Huo
, D. Tripathy
, N. Ueno

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S52-S53
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00941-8
State	Published - Oct 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/S0959-8049(22)00941-8

Cite this

@article{8e37eceaa4e74553a403f60388f28c2b,

title = "The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan, an anti-HER2 antibody-drug conjugate",

author = "J. Lee and K. Kida and H. Liu and Gi, \{Y. J.\} and G. Manyam and J. Wang and A. Multani and L. Huo and D. Tripathy and N. Ueno",

note = "Funding Information: Corporate-sponsored Research: Naoto Ueno has received a research grant from Daiichi Sankyo (Tokyo, Japan).",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00941-8",

language = "English (US)",

volume = "174",

pages = "S52--S53",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan, an anti-HER2 antibody-drug conjugate

AU - Lee, J.

AU - Kida, K.

AU - Liu, H.

AU - Gi, Y. J.

AU - Manyam, G.

AU - Wang, J.

AU - Multani, A.

AU - Huo, L.

AU - Tripathy, D.

AU - Ueno, N.

N1 - Funding Information: Corporate-sponsored Research: Naoto Ueno has received a research grant from Daiichi Sankyo (Tokyo, Japan).

PY - 2022/10

Y1 - 2022/10

UR - https://www.scopus.com/pages/publications/85140470691

UR - https://www.scopus.com/pages/publications/85140470691#tab=citedBy

U2 - 10.1016/S0959-8049(22)00941-8

DO - 10.1016/S0959-8049(22)00941-8

M3 - Article

AN - SCOPUS:85140470691

SN - 0959-8049

VL - 174

SP - S52-S53

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan, an anti-HER2 antibody-drug conjugate

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this